Literature DB >> 31809555

Evaluation of pre-analytic heat treatment protocol used in the CDC Nijmegen-Bethesda assay for heat inactivation of extended half-life haemophilia treatment products.

Amanda B Payne1, Dorothy Ellingsen1, Jennifer Driggers1, Christopher J Bean1, Connie H Miller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31809555      PMCID： PMC7523025          DOI： 10.1111/hae.13901

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  4 in total

1.  Heat inactivation of extended half-life factor VIII concentrates.

Authors:  Kara A Fylling; Julie I Tange; Dong Chen; Rajiv K Pruthi
Journal:  Haemophilia       Date:  2019-02-12       Impact factor: 4.287

2.  Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.

Authors:  C H Miller; S J Platt; A S Rice; F Kelly; J M Soucie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

Review 3.  Extended Half-Life Factor VIII and Factor IX Preparations.

Authors:  Lukas Graf
Journal:  Transfus Med Hemother       Date:  2018-03-21       Impact factor: 3.747

4.  Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Authors:  B Boylan; C H Miller
Journal:  Haemophilia       Date:  2018-02-20       Impact factor: 4.287
  4 in total
  3 in total

1.  Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels.

Authors:  Nasim Shahidi Hamedani; Johannes Oldenburg; Bernd Pötzsch; Jens Müller
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

2.  Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents.

Authors:  Brian Boylan; Glenn P Niemeyer; Bonnie Werner; Connie H Miller
Journal:  Haemophilia       Date:  2020-11-20       Impact factor: 4.263

Review 3.  An Update on Laboratory Diagnostics in Haemophilia A and B.

Authors:  Jens Müller; Wolfgang Miesbach; Florian Prüller; Thomas Siegemund; Ute Scholz; Ulrich J Sachs
Journal:  Hamostaseologie       Date:  2022-02-01       Impact factor: 2.145
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.